InvestorNewsBreaks

Thursday May 14, 2026 - 9:53 am

InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Emerging GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its featured placement in a BioMedWire editorial examining next-generation innovation in the rapidly expanding GLP-1 therapeutic market. The editorial highlights the company’s subsidiary GlucaPharm Inc. and its development of GEP-44, a novel triple agonist peptide designed to enhance efficacy, tolerability and delivery flexibility in the treatment of obesity, type 2 diabetes and related metabolic conditions. To view…

Thursday May 14, 2026 - 9:50 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic transformation toward an acquisition-driven growth model focused on clinical-stage neurology and oncology assets. Following quarter end, the company strengthened its balance sheet with a $22.5 million private placement, which, together with existing cash, is expected to support operations beyond 12 months as CNS pursues asset acquisitions and explores out-licensing opportunities…

Thursday May 14, 2026 - 9:44 am

InvestorNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Shareholders Approve All Proposals at Annual Meeting

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced that shareholders approved all proposals at its annual meeting held May 13, 2026, with 108.4 million shares, representing 62.84% of eligible outstanding shares, represented at the meeting. Shareholders elected all nominated directors, approved the appointment of auditors, and passed the company’s non-binding advisory vote on executive compensation. To view…

Thursday May 14, 2026 - 9:40 am

InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Receives 2026 Healthcare Innovation Award for Drug Resistance Research

Kairos Pharma (NYSE American: KAPA) announced it has been named a winner in the 2026 GHP Magazine Healthcare & Pharmaceutical Awards, receiving recognition as the USA leader in drug resistance development. The award highlights the company’s work in advancing cancer therapeutics designed to address treatment resistance, underscoring Kairos’ focus on extending the effectiveness of existing cancer therapies through innovative drug resistance-targeting approaches. To view the…

Thursday May 14, 2026 - 9:30 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Fibromyalgia Real-World Data at ISPOR 2026

Tonix Pharmaceuticals (NASDAQ: TNXP) announced a poster presentation at ISPOR 2026 highlighting findings from a retrospective cohort study analyzing U.S. claims data from adults with fibromyalgia between April 2021 and April 2024. The presentation will feature real-world insights related to fibromyalgia treatment, following the FDA approval of TONMYA(R) in August 2025 and its subsequent U.S. commercial launch in November 2025. To view the full press…

Thursday May 14, 2026 - 9:20 am

InvestorNewsBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Reports Record First-Quarter 2026 Financial Results, Reiterates Production Guidance

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising. G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) reported record first-quarter 2026 financial results, including net income of $80.4 million and free cash flow of $56.2 million, driven by strong margins at its Tocantinzinho mine amid higher realized gold prices. The company produced 31,846 ounces of payable gold…

Thursday May 14, 2026 - 9:12 am

InvestorNewsBreaks – New Pacific Metals Corp. (TSX: NUAG) (NYSE American: NEWP) Reports Fiscal 2026 Third-Quarter Financial Results, Maintains Strong Working Capital Position

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising. New Pacific Metals (TSX: NUAG) (NYSE American: NEWP) reported a net loss attributable to equity holders of $0.87 million for the three months ended March 31, 2026, compared with $0.86 million in the prior-year period, while maintaining working capital of $39.28 million as of quarter-end. The company highlighted a framework agreement signed with the Carangas community in February…

Thursday May 14, 2026 - 9:10 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack detection and ambulatory ECG patch initiatives, and an April public offering that raised $11.5 million in gross proceeds. The company reported a first-quarter net loss of $4.7 million, improved from $5.5 million in the prior-year period, with…

Thursday May 14, 2026 - 9:00 am

InvestorNewsBreaks – BOXABL, FG Merger II Advance Proposed Business Combination Following SEC Effectiveness of Form S-4

BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.S. Securities and Exchange Commission has declared effective the companies’ joint registration statement on Form S-4 related to their proposed business combination, marking a significant milestone in BOXABL’s path to becoming a publicly traded company. Shareholder meetings to approve the transaction are scheduled for June 9, 2026, with closing expected shortly thereafter, subject to customary conditions, after…

Thursday May 14, 2026 - 9:00 am

InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Announces Non-Brokered Private Placement of Up to $2 Million

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based leader in organic sedimentary phosphate exploration, announced plans to complete a non-brokered private placement of up to 11.1 million units at $0.18 per unit for gross proceeds of up to $2 million. Proceeds are expected to fund the phase…

Wednesday May 13, 2026 - 1:05 pm

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Eyes Next Growth Phase at Montauban

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, was featured in a recent article that discusses its momentum even amidst expected market volatility. “ESGold remains optimistic that gold’s stellar price will continue, given ongoing world debt and political pressures. Even…

Wednesday May 13, 2026 - 12:20 pm

InvestorNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Unveils Mudra Pro Neural Sensing Platform for AI and XR Innovation

Wearable Devices (NASDAQ: WLDS) announced the launch of Mudra Pro, a next-generation wearable neural sensing platform designed for developers, researchers, enterprise innovation teams and technology partners building AI, XR and human-machine interaction applications. The wrist-worn platform combines synchronized electromyography, photoplethysmography and inertial measurement sensors with embedded processing, sensor fusion and low-latency Bluetooth communication to support physiological state estimation, intent decoding, behavioral analytics and rapid prototyping, with the company…

Wednesday May 13, 2026 - 11:56 am

InvestorNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Taps Crypto, Traditional Finance Veteran to Drive Next Phase of Growth

Forward Industries (NASDAQ: FWDI), focused on building and managing a large-scale Solana (SOL) treasury, recently appointed Mark Brazier as its new CFO. “In his role as CFO, Brazier will oversee Forward’s financial operations, capital structure, financial reporting, capital markets activities, and more, as Forward Industries continues to operate and grow as the worlds-largest publicly traded Solana treasury company,” reads a recent article. “Mark brings an…

Wednesday May 13, 2026 - 11:55 am

InvestorNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Permanent Ukraine Operations to Accelerate Overwatch Adoption

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced plans to establish permanent operations in Ukraine through a wholly owned subsidiary to accelerate adoption of its Overwatch autonomous mission software across the country’s defense drone market. The expansion includes building an in-country commercial and technical team, opening a physical…

Wednesday May 13, 2026 - 10:45 am

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Announces First Patient Dosed in Phase 1b Trial of Sapu003

Oncotelic Therapeutics (OTCQB: OTLC), alongside Sapu Nano, announced that the first patient has been dosed in the Phase 1b clinical trial evaluating Sapu003, an investigational intravenous Deciparticle(TM) formulation of everolimus for patients with advanced mTOR-sensitive solid tumors. The open-label, dose-escalation study is designed to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity across patient cohorts including HR-positive/HER2-negative breast cancer and multiple additional tumor types, with Sapu003 developed as a weekly IV formulation…

Wednesday May 13, 2026 - 9:45 am

InvestorNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Software-Driven Drone Autonomy

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) was featured in AINewsWire editorial coverage examining the accelerating shift toward software-defined autonomous warfare, with the company highlighted for its Overwatch platform designed to provide GPS-denied navigation and precision targeting for low-cost drones operating in contested environments. The editorial emphasizes that while inexpensive drone hardware has become widely available and…

Wednesday May 13, 2026 - 9:37 am

InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) to Present at LD Micro Invitational XVI

Kairos Pharma (NYSE American: KAPA) announced that CEO and Chairman Dr. John Yu will present at the 16th Annual LD Micro Invitational on May 18, 2026, at 1:00 p.m. PDT at the Luxe Sunset Boulevard Hotel in Los Angeles, where he will provide an update on the company’s clinical program and partnering activities. To view the full press release, visit https://ibn.fm/g3aQY About Kairos Pharma, Ltd. Based in Los Angeles,…

Wednesday May 13, 2026 - 9:35 am

InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) was featured in BioMedWire editorial coverage examining the rapid growth of the GLP-1 market, with the company highlighted for its subsidiary GlucaPharm Inc. and its development of GEP-44, a patented triple agonist peptide licensed from Syracuse University. The editorial notes that GEP-44 is…

Wednesday May 13, 2026 - 9:20 am

InvestorNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Advances São Sepé Rare Earth Project With Drill Program Underway

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) provided an update on its São Sepé rare earth project in Brazil, where historical surface sampling identified three priority exploration targets prospective for ionic adsorption clay-hosted rare earth mineralization. The company has commenced an approximately 500-meter auger drill program, expected to run four to six weeks, to follow up on elevated rare earth oxide values and…

Wednesday May 13, 2026 - 9:20 am

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery

Oncotelic Therapeutics (OTCQB: OTLC) was featured in BioMedWire editorial coverage examining the growing urgency around effective central nervous system drug delivery, with the company highlighted for its proprietary intranasal nose-to-brain delivery platform designed to bypass the blood-brain barrier and deliver therapeutics directly to the brain. The editorial points to rising global Alzheimer’s cases and increased biodefense focus as major catalysts driving demand for faster, more…

Wednesday May 13, 2026 - 9:10 am

InvestorNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the…

Wednesday May 13, 2026 - 9:00 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Two May Investor Conferences

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated, commercial biotechnology company, announced that its management team will participate in two upcoming investor conferences in May 2026: the RBC Capital Markets Global Healthcare Conference on May 19 in New York and A.G.P.’s Annual Virtual Healthcare Conference on May 20. To view the full press release, visit https://ibn.fm/ZZpG2 Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is a fully-integrated, commercial-stage biotechnology company focused on central…

Wednesday May 13, 2026 - 9:00 am

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Enters $4.4 Million Registered Direct Offering

Lantern Pharma (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, announced a definitive agreement for the purchase and sale of 2,135,923 shares of common stock, or pre-funded warrants in lieu thereof, at $2.06 per share in a registered direct offering expected to generate approximately $4.4 million in gross proceeds. The company also announced a concurrent private placement of unregistered warrants and said it plans to…

Tuesday May 12, 2026 - 12:15 pm

InvestorNewsBreaks – Titan Partners Group LLC Expands Equity Research Division with Three Senior Analyst Appointments

Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, to significantly expand its equity research platform across technology, healthcare, and energy, power and infrastructure. The three analysts bring more than 40 years of combined middle-market equity research experience, strengthening Titan’s sector-focused research capabilities as the firm continues to build its investment banking platform focused on…

Tuesday May 12, 2026 - 11:29 am

InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Issues Initial Consideration Shares for Proposed HEAL Access Canada Acquisition

AI Maverick Intel (OTC: AIMV) announced the issuance of 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration under the companies’ Right of First Refusal Agreement dated Feb. 11, 2026, as AIMV advances its proposed acquisition of HEAL Access Canada Inc. The company said the total consideration tied to the transaction has been adjusted from 120 million to 100 million AIMV common shares, with…

Tuesday May 12, 2026 - 11:13 am

InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, with initial deep drill hole MM26-7 designed as a 100-meter step-back from last fall’s MM25-1 to further evaluate the thickness, continuity and phosphate grade characteristics of the Meade Peak…

Tuesday May 12, 2026 - 10:45 am

InvestorNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports Broad Gold Intercepts at Swanson Project

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Figure 1: Plan View of Swanson Deposit with currently reported drill holes LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) reported results from its ongoing drilling program at the Swanson Gold Project, highlighting broad and continuous gold mineralization that supports expansion potential beyond the current mineral resource model and planned…

Tuesday May 12, 2026 - 10:35 am

InvestorNewsBreaks – Bullish (NYSE: BLSH) to Acquire Equiniti in $4.2 Billion Transaction

Bullish (NYSE: BLSH) has entered into a definitive agreement to acquire Equiniti, the parent company of Notified and a global transfer agent and shareholder services provider, in a transaction valued at $4.2 billion. The acquisition is designed to position Bullish at the forefront of blockchain-native capital markets infrastructure by combining its institutional digital asset platform with Equiniti’s regulated transfer agent capabilities, which support nearly 3,000…

Tuesday May 12, 2026 - 10:00 am

InvestorNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka joined the latest episode of the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology designed to detect drug and alcohol intoxication through noninvasive speech analysis. During the interview, Hanka outlined the limitations of…

Tuesday May 12, 2026 - 9:45 am

InvestorNewsBreaks – Lunai Bioworks, Inc. (NASDAQ: LNAI) Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit

Lunai Bioworks (NASDAQ: LNAI) is the plaintiff in a federal securities fraud lawsuit filed in Delaware by national law firms Dickinson Wright and Fox Rothschild, alleging that unidentified “naked” short sellers engaged in a coordinated scheme to manipulate trading in the company’s common stock. The complaint alleges repeated violations of SEC Regulation SHO, including failures to deliver shares reaching as high as 234.6 times the maximum…

Tuesday May 12, 2026 - 9:44 am

InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its placement in a BioMedWire editorial examining the evolution of GLP-1 therapies and emerging innovation in obesity and metabolic disease treatment. The editorial highlights SureNano’s subsidiary GlucaPharm Inc. and its GEP-44 program, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in the rapidly expanding GLP-1 market, as demand continues to grow for…

Tuesday May 12, 2026 - 9:31 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress

Tonix Pharmaceuticals (NASDAQ: TNXP) reported first-quarter 2026 financial results while highlighting continued commercial momentum for TONMYA, its recently launched fibromyalgia treatment, and advancement across its clinical pipeline. The company said TONMYA, the first new fibromyalgia medicine in 15 years, has shown growth in prescriptions, prescribers, refills and patient access since its November 2025 launch, with a recently announced managed care agreement expanding potential coverage to approximately 35…

Tuesday May 12, 2026 - 9:20 am

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Report First Quarter 2026 Financial Results May 15

Lantern Pharma (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, announced that it will report its first-quarter 2026 operating and financial results via press release on May 15. The update will include financial results for the quarter ended March 31, 2026, along with operational updates regarding the company’s clinical trials and development of its proprietary artificial intelligence and machine learning platforms. To view the full press release, visit https://ibn.fm/g6WA2 About…

Tuesday May 12, 2026 - 9:20 am

InvestorNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its placement in a BioMedWire editorial exploring emerging technologies aimed at improving intoxication detection across law enforcement, workplace safety and healthcare settings. The editorial highlights MindBio’s development of an artificial intelligence-driven voice analysis platform designed to detect real-time impairment from…

Tuesday May 12, 2026 - 9:10 am

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining emerging breakthroughs in central nervous system drug delivery and the growing market opportunities tied to overcoming the blood-brain barrier. The editorial highlights Oncotelic’s proprietary intranasal nose-to-brain delivery platform, which is designed to enable rapid, targeted therapeutic access to the brain, positioning the company within a broader industry effort to advance next-generation treatments for…

Tuesday May 12, 2026 - 9:00 am

InvestorNewsBreaks – Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research

Qdrant’s vector database infrastructure supports the AI-powered research platform used by SAPU Bioscience, a subsidiary of Oncotelic Therapeutics Inc. (OTCQB: OTLC), enabling large-scale biomedical literature analysis SAPU’s platform has indexed 28 million PubMed abstracts into a single searchable collection, supporting AI-assisted research workflows and peer-reviewed scientific output The AI ecosystem aligns with Oncotelic’s broader strategy of integrating artificial intelligence, nanoparticle development and accelerated drug discovery platforms In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu,…

Tuesday May 12, 2026 - 9:00 am

InvestorNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Autonomous Drone Warfare Software

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its placement in an AINewsWire editorial exploring the growing role of software-driven autonomy in modern drone warfare. The editorial examines how low-cost drones are reshaping military strategy while highlighting the increasing importance of software that enables autonomous navigation and precision…

Monday May 11, 2026 - 2:24 pm

InvestorNewsBreaks – Pershing Square USA, Ltd. (NYSE: PSUS), Pershing Square Inc. (NYSE: PS) Close Combined Offerings Raising $5 Billion

Pershing Square USA (NYSE: PSUS) and Pershing Square Inc. (NYSE: PS) announced the closing of their combined initial public offerings and previously announced combined private placement, generating gross proceeds of $5 billion for PSUS before deducting sales loads, placement fees and offering expenses. The PSUS shares and PSI shares began trading on the New York Stock Exchange on April 29, 2026, under the symbols PSUS and PS, respectively. To view the…

Monday May 11, 2026 - 2:05 pm

InvestorNewsBreaks – Oregen Energy Corp. (CSE: ORNG) (OTCQB: ORGEF) (FSE: A1S0) Appoints Former Impact Oil & Gas Executive Philip Birch as Strategic Advisor

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising. Oregen Energy (CSE: ORNG) (OTCQB: ORGEF) (FSE: A1S0) announced the appointment of petroleum geoscientist and former Impact Oil & Gas Exploration Director Philip Birch as strategic advisor as the company evaluates a potential investment in Namibia’s offshore Block 2812Ab in the Orange Basin. Birch played a key role in…

Monday May 11, 2026 - 2:00 pm

InvestorNewsBreaks – Delta Gold Technologies PLC (Aquis: DGQ /OTC: DGQTF) Featured in Debut Episode of The Innovation Report Series on Quantum Technologies

Delta Gold Technologies (Aquis: DGQ /OTC: DGQTF) is featured in the debut episode of The Innovation Report Series, a new documentary initiative exploring technologies, industries and companies shaping the future global economy. The first episode, The Quantum Revolution, examines the advancing commercial potential of quantum technologies and their potential impact across industries, while the broader series explores the intersection of innovation, capital markets and industrial transformation. The upcoming second episode…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions